[
    [
        {
            "time": "2020-12-31",
            "original_text": "贝达药业2020年度净利同比增163% 拟10派3.1元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年度",
                    "净利",
                    "同比增163%",
                    "10派3.1元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业2020年度净利同比增163% 拟10派3.1元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "贝达药业(300558.SZ)拟使用不超15亿元闲置自有资金购买理财产品",
            "features": {
                "keywords": [
                    "贝达药业",
                    "300558.SZ",
                    "闲置自有资金",
                    "购买理财产品",
                    "15亿元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)拟使用不超15亿元闲置自有资金购买理财产品",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "贝达药业(300558.SZ)及子公司拟申请不超20亿元融资额度",
            "features": {
                "keywords": [
                    "贝达药业",
                    "300558.SZ",
                    "子公司",
                    "融资额度",
                    "20亿元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)及子公司拟申请不超20亿元融资额度",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "交卷！贝达药业：2020年度净利润约6.06亿元，同比增长162.70%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年度",
                    "净利润",
                    "6.06亿元",
                    "同比增长162.70%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "交卷！贝达药业：2020年度净利润约6.06亿元，同比增长162.70%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "贝达药业：2020年净利同比增162.7% 拟10派3.1元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年",
                    "净利",
                    "同比增162.7%",
                    "10派3.1元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：2020年净利同比增162.7% 拟10派3.1元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "贝达药业(300558.SZ)：2020年净利升162.7%至6.06亿元 拟10派3.1元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "300558.SZ",
                    "2020年",
                    "净利",
                    "升162.7%",
                    "6.06亿元",
                    "10派3.1元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)：2020年净利升162.7%至6.06亿元 拟10派3.1元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "贝达药业：2020年净利同比增长162.70% 拟10派3.1元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年",
                    "净利",
                    "同比增长162.70%",
                    "10派3.1元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：2020年净利同比增长162.70% 拟10派3.1元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "贝达药业：2020年净利润同比增长162.7%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年",
                    "净利润",
                    "同比增长162.7%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：2020年净利润同比增长162.7%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]